Literature DB >> 850423

Multiorgan scans for staging lung cancer. Correlation with clinical evaluation.

J W Ramsdell, R M Peters, A T Taylor, N P Alazraki, G M Tisi.   

Abstract

One hundred consecutive patients with findings suggestive of resectable bronchogenic carcinoma were studied prospectively to determine if routine liver, brain, and bone scans (multiorgan scans) detected metastases which were not suggested by a history, physical examination, and serum chemistries. Multiorgan scans were compared with clinical evaluations in 52 patients found to have operable bronchogenic carcinoma. There was a discordance between scans and clinical evaluations in 25/153 scans (16 per cent). Two of the 22 negative scans in patients with abnormal clinical findings were false negative. Sixteen of the 17 positive scans in patients with normal clinical findings were false positive. One of the 131 scans done in patients with no evidence of metastases on clinical evaluation was true positive. These data indicate that the routine use of multiorgan scans in the initial staging of potentially resectable bronchogenic carcinoma is not justified.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850423

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer.

Authors:  H Osada; Y Nakajima; Y Taira; K Yokote; T Noguchi
Journal:  Jpn J Surg       Date:  1987-09

2.  The staging of lung cancer.

Authors:  S Spiro; P Goldstraw
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

Review 3.  Staging for M disease.

Authors:  T L Winton
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 4.  The management of lung cancer.

Authors:  S G Spiro
Journal:  Lung       Date:  1982       Impact factor: 2.584

5.  Transcutaneous abdominal ultrasonography in the staging of lung cancer.

Authors:  P S Bakke; M Taule; E Lillo; G Melgren; I J Magnussen; O J Halvorsen
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

6.  Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.

Authors:  F Michel; M Solèr; E Imhof; A P Perruchoud
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

Review 7.  Selection of patients with non-small-cell lung carcinoma for surgical resection.

Authors:  N W Rizk
Journal:  West J Med       Date:  1985-11

Review 8.  Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer.

Authors:  T K Hillers; M D Sauve; G H Guyatt
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

9.  Detection of occult bone marrow micrometastases in patients with operable lung carcinoma.

Authors:  R J Cote; E J Beattie; B Chaiwun; S R Shi; J Harvey; S C Chen; A E Sherrod; S Groshen; C R Taylor
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

10.  Can clinical factors be determinants of bone metastases in non-small cell lung cancer?

Authors:  Ahmet Ursavas; Mehmet Karadag; Esra Uzaslan; Erkan Rodoplu; Ezgi Demirdögen; Basak Burgazlioglu; R Oktay Gozu
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.